Login / Signup

Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?

Javier EscuderoVictoria Heredia-SotoYinyin WangPatricia RuizYingying HuAlejandro GallegoJose Juan Pozo-KreilingerVirginia Martinez-MarinAlberto BerjonEduardo Ortiz-CruzDaniel BernabeuJaime FeliuJing TangAndres RedondoMarta Mendiola
Published in: Cancer cell international (2021)
Our results support the effect of eribulin on LPS, LMS and FS cell line models. The combination of eribulin with ifosfamide or pazopanib has shown in vitro synergy, which warrants further clinical research.
Keyphrases
  • metastatic breast cancer
  • phase ii
  • inflammatory response
  • clinical trial
  • open label
  • anti inflammatory
  • randomized controlled trial
  • study protocol
  • metastatic renal cell carcinoma